John Celebi

John Celebi is a declared insider of Faeth Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 15 February 2022 and 19 February 2025, the trades on record add up to 7 filings.

No open-market sale appears; the market trades are 1 purchase worth €395. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants.

Most recently, on 26 February 2025, the filings show a share grant worth €2,532 in Faeth Therapeutics, Inc. The last purchase on record was published on 13 September 2023, which is 1,131 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.